Company expected to face penalties exceeding $8bn while Sackler family members will avoid criminal charges in settlement
Purdue Pharma, the OxyContin prescription opioid painkiller maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve US justice department investigations into its alleged role in fueling the nation’s opioid crisis, six people familiar with the matter said.
Purdue lawyers and federal prosecutors are brokering a plea deal that could be unveiled as soon as within the next two weeks and include billions of dollars of financial penalties, four of the people said. They stressed that talks are fluid and that some of the terms could change as discussions continue.
Continue reading…Company expected to face penalties exceeding $8bn while Sackler family members will avoid criminal charges in settlementPurdue Pharma, the OxyContin prescription opioid painkiller maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve US justice department investigations into its alleged role in fueling the nation’s opioid crisis, six people familiar with the matter said.Purdue lawyers and federal prosecutors are brokering a plea deal that could be unveiled as soon as within the next two weeks and include billions of dollars of financial penalties, four of the people said. They stressed that talks are fluid and that some of the terms could change as discussions continue. Continue reading…